Incidence of primary cutaneous T-cell lymphoma in Norway

Saunes, Marit; Nilsen, Turid; Johannesen, Tom B.

doi:10.1111/j.1365-2133.2008.08852.x

Cited by 55 publications

(35 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based on recent analyses, the incidence of this cancer during 2000–2010 years reached ~10 cases per million individuals per year in the United States . Similarly, increase in CTCL incidence has been observed in other parts of the world . This malignancy often presents at an older age (i.e., >55 years old) in Caucasians, but in African‐American, Hispanic, and Middle‐Eastern individuals studies have shown an earlier age at presentation with a more aggressive clinical course .…”

Section: Introductionmentioning

confidence: 97%

Demographic patterns of cutaneous T‐cell lymphoma incidence in Texas based on two different cancer registries

et al. 2015

View full text Add to dashboard Cite

Cutaneous T-cell lymohomas (CTCLs) are rare, but potentially devastating malignancies, with Mycosis fungoides and Sézary Syndrome being the most common. In our previous study, we identified and described regions of geographic clustering of CTCL cases in Texas by analyzing ∼1990 patients using two distinct cancer registries. In the current work, we describe in detail demographic patterns for this malignancy in our study population and apply logistic regression models to analyze the incidence of CTCL by sex, race, age, and clinical stage at the time of diagnosis. Furthermore, using Fisher's exact test, we analyze changes in incidence over time in the identified Houston communities with unusually high CTCL incidence. While CTCL primarily affects Caucasian individuals >55 years old, we confirm that it presents at a younger age and with more advanced disease stages in African-American and Hispanic individuals. Also, we demonstrate a significant increase in CTCL incidence over time in the identified communities. Spring, Katy, and Houston Memorial areas had high baseline rates. Furthermore, a statistically significant disease surge was observed in these areas after ∼2005. This report supplements our initial study documenting the existence of geographic clustering of CTCL cases in Texas and in greater detail describes demographic trends for our patient population. The observed surge in CTCL incidence in the three identified communities further argues that this malignancy may be triggered by one or more external etiologic agents.

show abstract

Section: Introductionmentioning

confidence: 97%

Demographic patterns of cutaneous T‐cell lymphoma incidence in Texas based on two different cancer registries

et al. 2015

View full text Add to dashboard Cite

show abstract

“…6 in 1980-1984 to 2.9/1 000 000 in 2000-2003 in Norway 4. Comparison of percentage of subtypes of CTCL and CBCL of our study with the international literature.…”

mentioning

confidence: 56%

Disfiguring facial mycoses – a diagnostic and therapeutic challenge

Janappriya

Gunasekera

Keragala

et al. 2017

Acad Dermatol Venereol

View full text Add to dashboard Cite

“…1,4 The literature suggests that MF incidence may be increasing, but this may be an artifact due to improved diagnostic methods. 5,6 However, it is still an uncommon disorder, with approximately 0.18/100,000 person-years in Norway, for example. 6 A wide variety of treatment options is available, often tailored to a patient's stage and individual circumstances.…”

Section: Discussionmentioning

confidence: 99%

“…5,6 However, it is still an uncommon disorder, with approximately 0.18/100,000 person-years in Norway, for example. 6 A wide variety of treatment options is available, often tailored to a patient's stage and individual circumstances. 2 These options include corticosteroids, retinoids, bexarotene, PUVA, interferon-α, interferon-γ, and biologics (alemtuzumab), amongst others.…”

Section: Discussionmentioning

confidence: 99%

Homeopathy as Therapy for Mycosis Fungoides: Case Reports of Three Patients

Nwabudike¹

2019

Homeopathy

View full text Add to dashboard Cite

Background Mycosis fungoides (MF) is an uncommon, indolent, form of cutaneous T cell lymphoma, of which there are various types according to international classification. Various treatment modalities are available; however, these are fraught with potentially severe adverse effects. Methods Three cases of immunohistochemically confirmed MF were treated with classical individualized homeopathy. Each case was followed up with photographic documentation and was reported according to the criteria set out in the HOM-CASE guidelines. Based on the WHO-EORTC (World Health Organization–European Organization for Research and Treatment of Cancer) criteria, the patients were classified as T1b, T1a/T1b and T2b respectively. Results All cases remitted following homeopathic treatment and remained in remission. Side effects were not reported in these cases. Conclusions MF may respond to individualized homeopathic medicine. Although the case number here is small, MF is not a common disorder, spontaneous remission is not usually expected, and the disease may progress to a more severe form. Hence, these findings could serve as a basis for further research into the role of individualized homeopathic medicine in the treatment of MF.

show abstract

Incidence of primary cutaneous T-cell lymphoma in Norway

Abstract: The incidence of both CTCL and MF/SS increased in Norway during the period 1980-2003.

Cited by 55 publications

References 13 publications

Demographic patterns of cutaneous T‐cell lymphoma incidence in Texas based on two different cancer registries

Demographic patterns of cutaneous T‐cell lymphoma incidence in Texas based on two different cancer registries

Disfiguring facial mycoses – a diagnostic and therapeutic challenge

Homeopathy as Therapy for Mycosis Fungoides: Case Reports of Three Patients

Contact Info

Product

Resources

About